11-24738294-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001009909.4(LUZP2):āc.325C>Gā(p.Gln109Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,610,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001009909.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LUZP2 | NM_001009909.4 | c.325C>G | p.Gln109Glu | missense_variant | 4/12 | ENST00000336930.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LUZP2 | ENST00000336930.11 | c.325C>G | p.Gln109Glu | missense_variant | 4/12 | 1 | NM_001009909.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250472Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135392
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1458788Hom.: 0 Cov.: 29 AF XY: 0.00000964 AC XY: 7AN XY: 725850
GnomAD4 genome AF: 0.000217 AC: 33AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.325C>G (p.Q109E) alteration is located in exon 4 (coding exon 4) of the LUZP2 gene. This alteration results from a C to G substitution at nucleotide position 325, causing the glutamine (Q) at amino acid position 109 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at